Acknowledgements & Disclosures

Disclosures

Julie Johnson, Pharm.D has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Howard McLeod, Pharm.D. has disclosed that he is a consultant for Admin Health, is a member of Genetech’s speakers’ bureau, and is a shareholder for both Interpares Biomedicine and Cancer Genetics. No one else in a position to control content has any financial relationships to disclose.

Kiran Musunuru, M.D., Ph.D., M.P.H. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Peter O’Donnell, M.D. has disclosed that he is a former stockholder of PrescriptQ, Inc., a company which no longer exists and he no longer holds shares receives financial or material support from the University of Chicago for being named as a co-inventor on a pending patent for a genomic prescribing system. No one else in a position to control content has any financial relationships to disclose.

Dan M. Roden, M.D.C.M. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

David Nelson, M.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Josh F. Peterson, M.D., M.P.H. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Larisa Cavallari, Pharm. D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Craig Lee, Pharm. D., Ph.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Michael Pacanowski, Pharm.D., M.P.H. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Jeffrey Bishop, Pharm.D., M.S., BCPP, FCCP has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Carol Matthews, M.D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Meghan Arwood, Pharm.D., BCPS has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Michael Schuh, Pharm.D., M.B.A., FAPhA has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Elizabeth Clements, Pharm.D., BCACP has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Debra Barnette, Pharm.D., BCPS, BCACP, CDE, FCCPS has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Roger Fillingim, Ph.D. has disclosed that he is a stock shareholder with Algynomics. No one else in a position to control content has any financial relationships to disclose.

Siegfried Schmidt, M.D., Ph.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Cyrine-Eliana Haider, Pharm.D., BCPS, BCOP has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Kristin Weitzel, Pharm. D., CDE, FAPhA has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

J. Kevin Hicks, Pharm. D., Ph.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Mark Dunnenberger, Pharm. D has disclosed he is a consultant for Admera Health and Veritas Genetics.  No one else in a position to control content has any financial relationships to disclose.

Gillian Bell, Pharm.D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Max Smith III, Pharm.D., BCPS has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Rhonda M. Cooper-DeHoff, Pharm D, MS, FACC, FAHA, FCCP has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.